(OA14) Application of Tumor Treating Fields for Newly Diagnosed Glioblastoma Multiforme: Understanding of Nationwide Practice Patterns and Trends

Tumor treating fields (TTF) are a low-intensity, intermediate-frequency, non-invasive and regional anti-mitotic treatment that harnesses magnetic fields to induce apoptosis in targeted regions. A Food and Drug Administration-approved TTF system demonstrated a significant increase in survival of newly diagnosed glioblastoma multiforme (GBM) in 2014. One year later, in a landmark randomized phase III trial of newly diagnosed GBM patients, TTF + temozolomide demonstrated superiority to temozolomide alone.

https://ift.tt/2HOAAV2